| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/12/2004 | US6803048 Comprising oil phase, aqueous phase, and micronized inorganic pigments which have average particle size of less than 200 nm, and whose particles have both hydrophilic and lipophilic properties; cosmetics, dermatology |
| 10/12/2004 | US6803045 Cream or ointment applicator; nonirritating; avoids physical contact |
| 10/12/2004 | US6803044 Antimicrobial and anti-inflammatory peptides for use in human immunodeficiency virus |
| 10/12/2004 | US6803042 Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides |
| 10/12/2004 | US6803031 Aerosol comprises particles comprising at least 10 percent by weight of an erectile dysfunction drug, such as sildenafil, tadalafil or vardenafil. |
| 10/12/2004 | US6802811 Sensing, interrogating, storing, telemetering and responding medical implants |
| 10/12/2004 | US6802313 Charged particle emitter for generating charged particles, substrate located upon conductive plate, where charged particles, upon impact with predefined region of surface of substrate locally charge substrate and form powder cloud |
| 10/12/2004 | CA2306772C Use of c18 to c26 aliphatic alcohols for the manufacture of a medicament in the treatment of hyperproliferative skin disorders |
| 10/12/2004 | CA2170394C Process for conditioning substances |
| 10/12/2004 | CA2146006C Use of ergoline derivatives for the treatment of glaucoma |
| 10/07/2004 | WO2004086412A2 Radiation protection by gamma-tocotrienol |
| 10/07/2004 | WO2004085998A2 Biomimetic hierarchies using functionalized nanoparticles as building blocks |
| 10/07/2004 | WO2004085712A2 Multi-functional polymeric materials and their uses |
| 10/07/2004 | WO2004085483A2 Viscoelastic material |
| 10/07/2004 | WO2004085482A2 Method for producing starch networks and initial products |
| 10/07/2004 | WO2004084964A1 Porous calcium phosphate high molecular weight hydrogel composite having through hole, method for preparing the same, artificial bone or sustained release material for drug using the same |
| 10/07/2004 | WO2004084947A1 Pharmaceutical composition comprising fungal cell or fragment thereof |
| 10/07/2004 | WO2004084946A1 Pressure-sensitive adhesive for percutaneous absorption, pressure-sensitive adhesive composition for percutaneous absorption, and medicinal preparation for percutaneous absorption |
| 10/07/2004 | WO2004084934A1 Asthma preparation |
| 10/07/2004 | WO2004084908A1 Prostaglandin compositions for the treatment of erectile dysfunction |
| 10/07/2004 | WO2004084900A1 Topical formulation and use of buspirone |
| 10/07/2004 | WO2004084899A1 Medicinal composition containing pyrrolopyridazine compound |
| 10/07/2004 | WO2004084878A1 Compositions and methods for treatment of premature ejaculation |
| 10/07/2004 | WO2004084877A1 Composition for ophthalmic use |
| 10/07/2004 | WO2004084873A1 Oral delivery system comprising an antibacterial and an anti-inflammatory agent |
| 10/07/2004 | WO2004084872A1 Drug delivery device comprising a mesh sleeve |
| 10/07/2004 | WO2004084871A1 Intravenous nanoparticles for targenting drug delivery and sustained drug release |
| 10/07/2004 | WO2004084870A1 Solid oral dosage form containing seamless microcapsules |
| 10/07/2004 | WO2004084869A1 Matrix compositions for controlled delivery of drug substances |
| 10/07/2004 | WO2004084868A1 Morphine controlled release system |
| 10/07/2004 | WO2004084867A1 The colon-targeted pharmaceutical compositions of gastrointestinal motility drugs and their use |
| 10/07/2004 | WO2004084866A1 Method for coating drug-containing particles and formulations and dosage units formed therefrom |
| 10/07/2004 | WO2004084865A1 Formulations comprising an active ingredient and cocoa powder and use thereof |
| 10/07/2004 | WO2004084864A1 Formulations comprising tolterodine and cocoa powder and use thereof |
| 10/07/2004 | WO2004084863A1 Method of producing small microspheres of sugar, microspheres thus obtained and applications thereof |
| 10/07/2004 | WO2004084862A1 Process for the production of cross-linked gelatin beadlets |
| 10/07/2004 | WO2004084861A2 Angiogenesis promotion by prostaglandin compositions and methods |
| 10/07/2004 | WO2004084860A2 Methods for the comminution and stabilization of small particles in suspension |
| 10/07/2004 | WO2004084859A2 Nasal calcitonin formulations containing chlorobutanol |
| 10/07/2004 | WO2004084858A2 Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants |
| 10/07/2004 | WO2004084857A1 Medicament delivery device and a method of medicament delivery |
| 10/07/2004 | WO2004084856A2 Novel galenical system for active transport, method for preparation and use |
| 10/07/2004 | WO2004084839A2 Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin |
| 10/07/2004 | WO2004084826A2 Antifungal nail coat and method of use |
| 10/07/2004 | WO2004084819A2 Poly(acryloyl-hydroxyethyl starch)-plga composite microspheres |
| 10/07/2004 | WO2004084703A2 Temporary embolization using inverse thermosensitive polymers |
| 10/07/2004 | WO2004070562A9 System and method for notification and escalation of medical data alerts |
| 10/07/2004 | WO2004069198A3 Sugar-free oral transmucosal solid dosage forms and uses thereof |
| 10/07/2004 | WO2004069141A3 Transdermal granisetron |
| 10/07/2004 | WO2004066924A3 Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
| 10/07/2004 | WO2004066913A3 Solid mosapride preparation |
| 10/07/2004 | WO2004066910A8 Controlled release modifying complex and pharmaceutical compositions thereof |
| 10/07/2004 | WO2004066908A3 Composition containing cationic lipids and a polynucleotide or a polypeptide and method for the targeted delivery of active substances |
| 10/07/2004 | WO2004062561A3 Pharmaceutical compositions comprising fentanyl for intranasal delivery |
| 10/07/2004 | WO2004060353A9 Solid dispersions comprising a hygroscopic and/or deliquescent drug |
| 10/07/2004 | WO2004060345A3 Dispersible pharmaceutical compositions |
| 10/07/2004 | WO2004058156A3 High pressure spray-dry of bioactive materials |
| 10/07/2004 | WO2004047942A3 Method and apparatus for filtering and drying a product |
| 10/07/2004 | WO2004047729B1 Composition for the prevention and treatment of inflammation of the ear |
| 10/07/2004 | WO2004037316A3 Nanoparticle delivery system |
| 10/07/2004 | WO2004035754A3 Microencapsulation and sustained release of biologically active polypeptides |
| 10/07/2004 | WO2004016242A8 A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles |
| 10/07/2004 | WO2004010934A3 Methods for the use of neurotoxin in the treatment of urologic disorders |
| 10/07/2004 | WO2004004757A8 Treatment for eye disorder |
| 10/07/2004 | WO2004002402A3 Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid |
| 10/07/2004 | WO2003091276A3 Compositions and methods of use of peptides in combination with biocides and/or germicides |
| 10/07/2004 | WO2003074027A8 Self emulsifying drug delivery systems for poorly soluble drugs |
| 10/07/2004 | US20040199146 System and method for monitoring power source longevity of an implantable medical device |
| 10/07/2004 | US20040199145 Antibiotic drug delivery system |
| 10/07/2004 | US20040199136 Article having a lotioned topsheet |
| 10/07/2004 | US20040198901 Random block copolymers |
| 10/07/2004 | US20040198843 mixture of hydrophobic and polarity moiety; high pressure homogenization of crude oil and water |
| 10/07/2004 | US20040198838 Administering by mouth; side effect reduction; multilayer coating on tablet; fungicides |
| 10/07/2004 | US20040198829 Adjust transportation of active material to eye |
| 10/07/2004 | US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 10/07/2004 | US20040198817 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
| 10/07/2004 | US20040198813 Novel microemulsion and micelle systems for solubilizing drugs |
| 10/07/2004 | US20040198812 Pseudopolymorphic forms of carvedilol |
| 10/07/2004 | US20040198763 Usign tacrolimus; eye drops |
| 10/07/2004 | US20040198760 Anticancer agents ; skins, prostate glands, lungs, breasts, leukemia, central nervous system, colon |
| 10/07/2004 | US20040198709 Compositions and methods for enhancing corticosteroid delivery |
| 10/07/2004 | US20040198708 For orienting and positioning a capsule containing a dry powder pharmaceutical formulation ( a short-acting bronchodilator and a corticosteroid) to be administered via inhalation to a patient with a pulmonary disease |
| 10/07/2004 | US20040198706 active agent (not testosterone alone ) and a delivery vehicle containing an alkanol, a polyalcohol, and a permeation enhancer to provide permeation enhancement of the active mammalian dermal or mucosal surface; free of long chain fatty acid, fatty ester and fatty alcohol to avoid odor and irritation |
| 10/07/2004 | US20040198699 Composition and method for the treatment of dysglucaemia |
| 10/07/2004 | US20040198696 Agent and food for inhibiting IgE antibody |
| 10/07/2004 | US20040198688 for treatment of atopic conditions (dermatitis, allergies); point mutations |
| 10/07/2004 | US20040198676 topical veterinary formulations, such as spot-on and pour-on formulations, which are used in treating, controlling and preventing of endo and ectoparasite infections in warm-blooded animals or birds, such as horses, cattle, sheep, pigs and pets |
| 10/07/2004 | US20040198673 Composition for epigallocatechin gallate |
| 10/07/2004 | US20040198671 Estrogenic component comprising estetrol and estetrol-like substances, which has relatively low estrogenic potency, metabolic stability, long half-life; triene steroids; osteoporosis, arteriosclerosis, cognitive disturbances, Alzheimer's disease, peri- or post-menopausal disorders |
| 10/07/2004 | US20040198662 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders |
| 10/07/2004 | US20040198646 dissolving water insoluble drugs in menthol; improved consistency of bioavailability |
| 10/07/2004 | US20040198645 Pharmaceutical compositions |
| 10/07/2004 | US20040198644 Integrin inhibitors for the treatment of eye diseases |
| 10/07/2004 | US20040198641 Hydrophobic core coupled to plurality of hydrophilic moieties that form micelles in solution; encapsulate lipoproteins; atherosclerosis; cardiovascular disorders |
| 10/07/2004 | US20040198634 Docusate sodium and/or ethylene oxide-propylene oxide copolymer wetting agent and megestrol acetate; storage stability, shelf life; free of polyethylene glycol, propylene glycol, sorbitol or glycerol |
| 10/07/2004 | US20040197883 Apparatus and method for electroporation of biological samples |
| 10/07/2004 | US20040197502 Heat generating article |
| 10/07/2004 | US20040197469 Apparatus and method for preparing microparticles |
| 10/07/2004 | US20040197426 Use of phyllanthus constituents for treating or preventing infections caused by hepatit |
| 10/07/2004 | US20040197422 an antibacterial agent (hepenicillin, cephalosporin, cloxacillin and cloxacillin benzath) in an oil-base (peanut oil) and a seal formulation comprising a gel base (aluminium stearate) and a non-toxic heavy metal salt (bismuth sub-nitrate); cattle |